CELGENE CORP /DE/ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CELGENE CORP /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is a 10% Owner in BRISTOL MYERS SQUIBB CO ($BMY) and a in CELGENE CORP /DE/ ($CELG) and a 10% Owner in CELGENE CORP /DE/ ($CELG) and a 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and a 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and a in ACCELERON PHARMA INC ($XLRN) and a 10% Owner in ACCELERON PHARMA INC ($XLRN) and a in SUTRO BIOPHARMA INC ($STRO) and a 10% Owner in Abraxis BioScience, Inc. ($ABII) and a 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and a 10% Owner in CRISPR Therapeutics AG ($CRSP).

Address: 86 MORRIS AVENUE SUMMIT 07901 NJ

Companies in which CELGENE CORP /DE/ is an Insider

Abraxis BioScience, Inc.

Trading Symbol: ABII
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 100 shares
Latest Transaction: Oct 18 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $166,435,229
Latest Transaction: Jul 13 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Adynxx, Inc.

Trading Symbol: ALQA
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,342,377 shares
Current Value: $4,038,307
Latest Transaction: Apr 13 2017
$ALQA Market Capitalization: $17.78M
$ALQA Previous Close: $0.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AGIOS PHARMACEUTICALS, INC.

Trading Symbol: AGIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 1,777,824 shares
Current Value: $78,970,942
Latest Transaction: Nov 14 2019
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BRISTOL MYERS SQUIBB CO

Trading Symbol: BMY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $362,175,397
Latest Transaction: Jul 13 2020
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CASI Pharmaceuticals, Inc.

Trading Symbol: CASI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 23,750,000 shares
Current Value: $33,012,500
Latest Transaction: Apr 01 2005
$CASI Market Capitalization: $81.26M
$CASI Previous Close: $1.39

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CELGENE CORP /DE/

Trading Symbol: CELG
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $815,069,911
Latest Transaction: Jul 13 2020
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 4,812,221 shares
Current Value: $75,792,481
Latest Transaction: Dec 07 2017
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SUTRO BIOPHARMA, INC.

Trading Symbol: STRO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/:
Holdings: 1,726,197 shares
Latest Transaction: Oct 02 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of CELGENE CORP /DE/

Sentiment: All, ABII, XLRN, ALQA, AGIO, BMY, CASI, CELG, CRSP, STRO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 13 2020BMYBRISTOL MYERS SQUI ...CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970

View all CELGENE CORP /DE/ insider transactions.

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

What Do the Transaction Codes Mean?

Each transaction listed on the Form 4 filing must be marked with a transaction code. Here is a list and description of transaction codes as used and categorized by the SEC. More ...

What Is Illegal Insider Trading?

Illegal Insider trading occurs when a trade has been influenced by the possession of "material" and "non-public" information about the security. Because such information is not available to other investors, a person using it is trying to gain an unfair advantage over others. More ...

Contact us | Follow us on Twitter